Live In Play

Live In Play®

Updated: 28-May-24 07:09 ET

ATRI: ATRION to be acquired by Nordson (NDSN) for $460.00/share in cash (462.93)

Co announced that it has entered into a definitive agreement to acquire Atrion Corporation (ATRI) for $460.00 per share in cash. This reflects a valuation of 15X Atrion's 2024 full-year estimated EBITDA, inclusive of synergies Nordson expects to generate in the first two years of its ownership. The acquisition expands Nordson's medical portfolio into new markets and therapies, supported by long-term secular growth trends.
The $460.00 per share in cash price for Atrion represents a total transaction enterprise value of approximately $800 million. The transaction is expected to close prior to Nordson's fiscal year-end 2024, pending applicable regulatory and stockholder approvals and will be funded through a combination of cash on hand and newly issued financial debt.